Image-Guided Radiation Therapy Market is Expected to Reach $2.4 billion | MarketsandMarkets.

Chicago, Sept. 14, 2023 (GLOBE NEWSWIRE) — The image-guided radiation therapy (IGRT) industry is poised for remarkable growth in the near future, driven by advancements in medical imaging technologies, increased patient demand for personalized cancer treatments, and the continuous refinement of radiation therapy delivery techniques. This burgeoning sector promises to revolutionize cancer care by enhancing treatment precision and minimizing collateral damage to healthy tissues. With the integration of artificial intelligence and machine learning algorithms for real-time tumor tracking and adaptation, IGRT is expected to further streamline treatment workflows and improve patient outcomes. As research and development efforts continue to push the boundaries of innovation, the IGRT industry is set to play a pivotal role in shaping the future of oncology, offering hope for more effective and less invasive cancer treatments.

Image-Guided Radiation Therapy market in terms of revenue was estimated to be worth $1.9 billion in 2023 and is poised to reach $2.4 billion by 2028, growing at a CAGR of 5.2% from 2023 to 2028 according to a latest report published by MarketsandMarkets™. The image-guided radiation therapy market is driven by several factors that contribute to its growth and increasing adoption. These driving factors include non-invasive cancer treatments, the increasing prevalence of the cancer patient population and rising government initiatives for cancer management. However, the complexity in imaging technology and affordability limits the market growth of the image-guided radiation therapy market.

Download an Illustrative overview:

Image-Guided Radiation Therapy Market Scope:

Report Coverage Details
Market Revenue in 2023 $1.9 billion
Estimated Value by 2028 $2.4 billion
Growth Rate Poised to grow at a CAGR of 5.2%
Market Size Available for 2020–2028
Forecast Period 2023–2028
Forecast Units Value (USD Billion)
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered Product, Procedure, Application, End User, and Region
Geographies Covered North America, Europe, Asia Pacific, Latin America and Middle East & Africa
Report Highlights Updated financial information / product portfolio of players
Key Market Opportunities Rising healthcare expenditure across developing countries
Key Market Drivers Increase in non-invasive cancer treatments through radiation therapy

Image-Guided Radiation Therapy market major players covered in the report, such as:

  • Siemens Healthineers AG (Germany)
  • Hitachi (Japan)
  • Elekta (Sweden)
  • Koninklijke Philips (Netherlands)
  • Viewray Technologies Inc. (US)
  • C-RAD (Sweden)
  • Varian Medical Systems (US)
  • Toshiba Corporation (Japan)
  • General Electric Healthcare Company (US)
  • IBA Worldwide (Belgium)
  • Accuray Incorporated (US)
  • Becton, Dickinson and Company (US)
  • Vision RT Ltd. (UK)
  • and Among Others

Buy an Image-Guided Radiation Therapy Industry Report (200 Pages PDF with Insightful Charts, Tables, and Figures):

This report has segmented the global image-guided radiation therapy market based on product, procedure, application, end-user, and region.

IGRT Market, By Product Type

  • 4D gating/4D RT
  • LINAC (Linear Accelerator)
  • PET/MRI- guided radiation therapy
  • Portal Imaging
  • CT scanning

IGRT Market, By Application

  • Head and neck cancers
  • Prostate cancer
  • Lung cancer
  • Breast cancer
  • Gynecological cancers
  • Gastrointestinal cancers
  • Central nervous system

IGRT Market, By Procedure

  • Intensity-modulation radiation therapy
  • 3D Conformal Radiation therapy
  • Stereotactic therapy
  • Proton beam therapy
  • Particle therapy
  • IGRT Market, By End User
  • Hospitals
  • Independent Radiotherapy Centers

IGRT Market, by region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
  • MEA

Request for FREE Sample Pages:

The key stakeholders in the Image-Guided Radiation Therapy market include:

  • Radiotherapy product manufacturers
  • Distributors, suppliers, and commercial service providers
  • Healthcare service providers
  • Clinical research organizations (CROs)
  • Radiotherapy service providers
  • Radiotherapy product distributors
  • Medical research laboratories
  • Cancer care centers
  • Cancer research organizations
  • Academic medical centers and universities
  • Market research and consulting firms

Recent Developments:

  • In 2023, Philips extended the company’s mobile C-arm portfolio with Zenition 10.
  • In 2023, GE HealthCare Advances PET/MR Capabilities with AIR Technologies to enhance diagnostic precision and simplify treatment evaluation while elevating patient comfort.
  • In 2023, The launch of Pixxoscan expands GE HealthCare’s portfolio of Magnetic Resonance Imaging (MRI) contrast agents, now offering two leading macrocyclic molecules to customers – Clariscan (gadoteric acid) and Pixxoscan (gadobutrol).

Frequently Asked Questions (FAQs) of Image-Guided Radiation Therapy Market:

Question 1: What is the expected addressable market value of the global image-guided radiation therapy market over five years?
Answer: The global image-guided radiation therapy market will reach USD 2.4 Billion by 2028 from USD  1.9 Billion in 2022, at a CAGR of 5.2% from 2020 to 2028.

Question 2: Which segment based on application is expected to garner the highest traction within the image-guided radiation therapy market?
Answer: The product segment, which includes PET/ MRI-guided radiation therapy, is expected to grow at the highest rate.

Question 3: What are the strategies adopted by the top market players to penetrate emerging regions?
Answer: The major players in the market use partnerships, distribution agreements, product launches, and product approvals as important growth tactics

Question 4: What are the major factors expected to limit the growth of image-guided radiation therapy?
Answer: Complexity of imaging technology for treatments, Dearth of skilled radiologists/oncologists, and high cost of treatment. The availability of alternative technology is the major challenge the market faces.

Question 5: Which segment based on procedure is expected to garner the highest traction within the image-guided radiation therapy market?
Answer: In the procedure segment, Stereotactic Therapy is expected to grow at the highest rate.

Get 10% Free Customization on this Report:

Report Objectives:

  • To define, describe, and forecast the Image-guided radiation therapy market based on product, procedure, application, end user, and region.
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze the micro markets with respect to individual growth trends, prospects, and contributions to the total market.
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders.
  • To profile the key market players and comprehensively analyze their market shares and core competencies.
  • To forecast the revenue of the market segments with respect to five main regions, namely, North America (US and Canada), Europe (Germany, France, the UK, Italy, Spain, and Rest of Europe), the Asia Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and the Middle East & Africa.
  • To track and analyze competitive developments such as new product launches and approvals; agreements, partnerships, expansions, acquisitions; and collaborations in the Image-guided radiation therapy market.

Related Reports:

Contrast Enhanced Ultrasound Market

Chemiluminescence Immunoassay Market

Near Infrared Imaging Market

Radiotherapy Market

Particle Counters Market

Research Insight:

Content Source:

CONTACT: About MarketsandMarkets™ MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients. Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes. The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry. To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook. Contact: Mr. Aashish Mehra MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441 Email:

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. IndiaShorts takes no editorial responsibility for the same.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More